Velcade 3.5 mg

Generic name: Bortezomib – Injection

This medication is a cancer chemotherapy drug used to treat certain types of tumors (e.g., multiple myeloma). It blocks certain proteins which helps to slow the growth and spread of the cancer.
This medication is given by injection into a vein by a healthcare professional. The dosage is based on your medical condition and response to therapy. It is important to drink plenty of fluids while you are being treated with this drug to prevent becoming dehydrated. Read the Patient Information Leaflet that comes with this drug, and consult your doctor or pharmacist if you have any questions.
Velcade is given by injection into a vein (intravenously) through a fine tube (cannula). It may be given through a central line, which is inserted under the skin into a vein near your collarbone, or through a PICC line, which is inserted into a vein in the crook of your arm. Velcade is usually given as four doses over a three-week period. The doses are given on the first and fourth day of the first two weeks, followed by a 10-day rest period. This completes one cycle of treatment. You can have up to eight cycles of treatment over 6 months.

Side effects:
mild nausea, vomiting, upset stomach;
diarrhea, constipation;
headache, blurred vision, dizziness;
muscle pain, bone or joint pain;
sleep problems (insomnia);
mild rash or itching; or
skin irritation where the medicine was injected.